Similarly, due to its effective suppression of tumor growth in murine HCC models [167], OPB-31121, a potent STAT3 inhibitor, was administered to 23 patients with progressive HCC at varying doses. This evidence concerns the gene STAT3 and hepatocellular carcinoma.